292 related articles for article (PubMed ID: 31529254)
21. Imaging biomarkers for well and moderate hepatocellular carcinoma: preoperative magnetic resonance image and histopathological correlation.
Huang K; Dong Z; Cai H; Huang M; Peng Z; Xu L; Jia Y; Song C; Li ZP; Feng ST
BMC Cancer; 2019 Apr; 19(1):364. PubMed ID: 30999947
[TBL] [Abstract][Full Text] [Related]
22. Adding ancillary features to enhancement patterns of hepatocellular carcinoma on gadoxetic acid-enhanced magnetic resonance imaging improves diagnostic performance.
Min JH; Kim YK; Sinn DH; Choi SY; Jeong WK; Lee WJ; Ha SY; Ahn S; Kim MJ
Abdom Radiol (NY); 2018 Sep; 43(9):2309-2320. PubMed ID: 29470629
[TBL] [Abstract][Full Text] [Related]
23. Nomogram development and validation to predict hepatocellular carcinoma tumor behavior by preoperative gadoxetic acid-enhanced MRI.
Tang M; Zhou Q; Huang M; Sun K; Wu T; Li X; Liao B; Chen L; Liao J; Peng S; Chen S; Feng ST
Eur Radiol; 2021 Nov; 31(11):8615-8627. PubMed ID: 33877387
[TBL] [Abstract][Full Text] [Related]
24. Hepatocellular carcinoma detection in liver cirrhosis: diagnostic performance of contrast-enhanced CT vs. MRI with extracellular contrast vs. gadoxetic acid.
Semaan S; Vietti Violi N; Lewis S; Chatterji M; Song C; Besa C; Babb JS; Fiel MI; Schwartz M; Thung S; Sirlin CB; Taouli B
Eur Radiol; 2020 Feb; 30(2):1020-1030. PubMed ID: 31673837
[TBL] [Abstract][Full Text] [Related]
25. High-flow haemangiomas versus hypervascular hepatocellular carcinoma showing "pseudo-washout" on gadoxetic acid-enhanced hepatic MRI: value of diffusion-weighted imaging in the differential diagnosis of small lesions.
Nam SJ; Yu JS; Cho ES; Kim JH; Chung JJ
Clin Radiol; 2017 Mar; 72(3):247-254. PubMed ID: 27789027
[TBL] [Abstract][Full Text] [Related]
26. Subtraction Images of Gadoxetic Acid-Enhanced MRI: Effect on the Diagnostic Performance for Focal Hepatic Lesions in Patients at Risk for Hepatocellular Carcinoma.
Choi SH; Kim SY; Lee SS; Shim JH; Byun JH; Baek S; Lee MG
AJR Am J Roentgenol; 2017 Sep; 209(3):584-591. PubMed ID: 28609188
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings.
Lee DH; Lee JM; Baek JH; Shin CI; Han JK; Choi BI
Radiology; 2015 Jan; 274(1):149-60. PubMed ID: 25203131
[TBL] [Abstract][Full Text] [Related]
28. Subcentimeter hepatocellular carcinoma in treatment-naïve patients: noninvasive diagnostic criteria and tumor staging on gadoxetic acid-enhanced MRI.
Hwang SH; Hong SB; Park S; Han K; Park YN; Kim SY; Park MS
Eur Radiol; 2021 Apr; 31(4):2321-2331. PubMed ID: 33044650
[TBL] [Abstract][Full Text] [Related]
29. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
Lee MH; Kim SH; Park MJ; Park CK; Rhim H
AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
[TBL] [Abstract][Full Text] [Related]
30. Comparison of diagnostic performance of non-contrast MRI and abbreviated MRI using gadoxetic acid in initially diagnosed hepatocellular carcinoma patients: a simulation study of surveillance for hepatocellular carcinomas.
Whang S; Choi MH; Choi JI; Youn SY; Kim DH; Rha SE
Eur Radiol; 2020 Aug; 30(8):4150-4163. PubMed ID: 32166493
[TBL] [Abstract][Full Text] [Related]
31. Quantitative image features of gadoxetic acid-enhanced MRI for predicting glypican-3 expression of small hepatocellular carcinoma ≤3 cm.
Dong SY; Sun W; Xu B; Wang WT; Yang YT; Chen XS; Zeng MS; Rao SX
Clin Radiol; 2023 Oct; 78(10):e764-e772. PubMed ID: 37500336
[TBL] [Abstract][Full Text] [Related]
32. Magnetic resonance texture analysis for the identification of cytokeratin 19-positive hepatocellular carcinoma.
Wang HQ; Yang C; Zeng MS; Rao SX; Ji Y; Weng X; Wang JY; Sheng RF
Eur J Radiol; 2019 Aug; 117():164-170. PubMed ID: 31307643
[TBL] [Abstract][Full Text] [Related]
33. MR-imaging features of hepatocellular carcinoma capsule appearance in cirrhotic liver: comparison of gadoxetic acid and gadobenate dimeglumine.
Dioguardi Burgio M; Picone D; Cabibbo G; Midiri M; Lagalla R; Brancatelli G
Abdom Radiol (NY); 2016 Aug; 41(8):1546-54. PubMed ID: 27052455
[TBL] [Abstract][Full Text] [Related]
34. A gadoxetic acid-enhanced MRI-based model using LI-RADS v2018 features for preoperatively predicting Ki-67 expression in hepatocellular carcinoma.
Liang Y; Xu F; Mou Q; Wang Z; Xiao C; Zhou T; Zhang N; Yang J; Wu H
BMC Med Imaging; 2024 Jan; 24(1):27. PubMed ID: 38273242
[TBL] [Abstract][Full Text] [Related]
35. Gadoxetic acid-enhanced magnetic resonance imaging characteristics of hepatocellular carcinoma occurring in liver transplants.
Kim M; Kang TW; Jeong WK; Kim YK; Kim SH; Kim JM; Sinn DH; Kim MJ; Jung SH
Eur Radiol; 2017 Aug; 27(8):3117-3127. PubMed ID: 27957635
[TBL] [Abstract][Full Text] [Related]
36. Gadoxetic acid-enhanced MRI as a predictor of recurrence of HCC after liver transplantation.
Lee S; Kim KW; Jeong WK; Kim MJ; Choi GH; Choi JS; Song GW; Lee SG
Eur Radiol; 2020 Feb; 30(2):987-995. PubMed ID: 31471754
[TBL] [Abstract][Full Text] [Related]
37. Detection of recurrent hepatocellular carcinoma after surgical resection: Non-contrast liver MR imaging with diffusion-weighted imaging versus gadoxetic acid-enhanced MR imaging.
Min JH; Kim YK; Choi SY; Kang TW; Jeong WK; Kim K; Won HJ
Br J Radiol; 2018 Oct; 91(1090):20180177. PubMed ID: 29927634
[TBL] [Abstract][Full Text] [Related]
38. T1 mapping combined with Gd-EOB-DTPA-enhanced magnetic resonance imaging in predicting the pathologic grading of hepatocellular carcinoma.
Chen CY; Chen J; Xia CC; Huang ZX; Song B
J Biol Regul Homeost Agents; 2017; 31(4):1029-1036. PubMed ID: 29254310
[TBL] [Abstract][Full Text] [Related]
39. Computer-aided hepatocellular carcinoma detection on the hepatobiliary phase of gadoxetic acid-enhanced magnetic resonance imaging using a convolutional neural network: Feasibility evaluation with multi-sequence data.
Cho Y; Han YE; Kim MJ; Park BJ; Sim KC; Sung DJ; Han NY; Park YS
Comput Methods Programs Biomed; 2022 Oct; 225():107032. PubMed ID: 35930863
[TBL] [Abstract][Full Text] [Related]
40. Prediction for Aggressiveness and Postoperative Recurrence of Hepatocellular Carcinoma Using Gadoxetic Acid-Enhanced Magnetic Resonance Imaging.
Lu M; Qu Q; Xu L; Zhang J; Liu M; Jiang J; Shen W; Zhang T; Zhang X
Acad Radiol; 2023 May; 30(5):841-852. PubMed ID: 36577606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]